By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS








Company News
Hemispherx (HEB) Enhances Ampligen Manufacturing And Scientific Capabilities 6/1/2017 1:51:23 PM
Hemispherx (HEB) Repurposes Ampligen In Immuno-Oncology 6/1/2017 8:17:55 AM
Hemispherx (HEB) Announces Financial Results For The Three Months Ended March 31, 2017 5/16/2017 11:08:19 AM
Hemispherx (HEB) Announces Financial Results For The Year Ended December 31, 2016 4/3/2017 2:07:42 PM
Hemispherx (HEB) Announces Conference Call Regarding Financial Results For The Year Ended December 31, 2016 4/3/2017 1:41:23 PM
Hemispherx (HEB) Meets Ampligen Sales Milestone In The 1st Quarter Of 2017 3/6/2017 10:19:31 AM
Hemispherx (HEB) Announces $1 Million Registered Direct Offering 2/2/2017 10:32:51 AM
Hemispherx (HEB) Announces First Shipment Of Newly Manufactured Rintatolimod (Ampligen) For Sale To Early Access Program In Europe 1/27/2017 8:05:52 AM
Hemispherx (HEB) Announces First Shipment Of Newly Manufactured Rintatolimod (Ampligen) For Sale To Early Access Program In Europe 1/26/2017 12:01:33 PM
Hemispherx (HEB) Release: Biopharma Announces Extension Of Rintatolimod European Early Access Program (EAP) To Pancreatic Cancer Patients 1/11/2017 7:06:12 AM
12345678910...
//-->